This study evaluated a pharmacist-led medication-safety program in hospitalized patients. The program included routine inpatient medication review and the use of smartphone-based clinical decision-support applications to identify potential medication issues and support therapeutic decision-making. The study was conducted in both adult and pediatric inpatients as part of routine clinical care. No investigational drugs or devices were used.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Medication-Safety Composite Indicator
Timeframe: From hospital admission through study completion (an average of 5 days)
Medication-Safety Composite Indicator
Timeframe: From hospital admission through study completion (an average of 5 days)